技術資料：Genedata Selector - インハウスの次世代シーケンス（NGS）で費用対効果を11倍に

Outsourcing NGS is costly and slow as the number of tests grow. This one-pager shows how leading biopharma companies are cutting turnaround by 90% and achieving up to 11x ROI by bringing NGS in-house with Genedata Selector^®.

Inside, you’ll discover:

• How to reduce timelines from months to days
• How to lower costs as volumes grow
• Why in-house NGS unlocks economies of scale

Download now and learn how to transform NGS operations for speed, savings, and control.